FluidIQ & Echas

At Beacon Angel’s first meeting of 2023, members entertained funding proposals from the following:

  • FluidIQ, developing a lung-safe, gas-powered respiratory resuscitator for use by EMTs and emergency doctors; and
  • Echas, enabling an individual suffering from a possible heart attack or stroke to self-diagnose using his smartphone.

Members discussed the funding rounds by Series number, of:

  • S 86B Lenoss Medical;
  • S 106 Xeno;
  • S 96B NF2 Therapeutics;
  • S 104 Hilltop Biosciences;
  • S 108 AOA Dx; and
  • S 109 QSM Dx.